Biodesix, Inc.: H.C. Wainwright raises target price to $38 from $27
BDSX•H.C. Wainwright raised its target price for Biodesix to $38 from $27.
Related News
Donaldson net earnings rise 23.7% to $453.8 million in FY26; sales increase 5.3% to $3.89 billion
DCI•
Moleculin says Annamycin preclinical data show CD8+ T cell-mediated activity in pancreatic cancer models
MBRX•
Trading in WYY halted pending news
WYY•
Nasdaq halts trading for volatility at 12:45 p.m.
SHMD•
Trump says Treasury's Bessent will not be his AI czar
QQQ•